10.01.20|Yoghev KarmelAt 43, Technion researcher Avi Schroeder is a phenomenon with four startups under his belt, working to cure cancer with elephant protein and trying to personalize chemotherapy. In between, the kosher-keeping Yeshiva graduate is taking on a deadly shrimp plague